A detailed history of Allianz Asset Management Gmb H transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 691,490 shares of TEVA stock, worth $15.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
691,490
Previous 610,195 13.32%
Holding current value
$15.3 Million
Previous $9.92 Million 25.67%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$15.81 - $18.96 $1.29 Million - $1.54 Million
81,295 Added 13.32%
691,490 $12.5 Million
Q2 2024

Aug 13, 2024

SELL
$12.78 - $17.4 $9.49 Million - $12.9 Million
-742,370 Reduced 54.89%
610,195 $9.92 Million
Q1 2024

May 13, 2024

SELL
$10.67 - $14.43 $8.01 Million - $10.8 Million
-750,249 Reduced 35.68%
1,352,565 $19.1 Million
Q4 2023

Feb 12, 2024

SELL
$8.12 - $10.63 $6.45 Million - $8.45 Million
-794,934 Reduced 27.43%
2,102,814 $22 Million
Q3 2023

Nov 13, 2023

SELL
$7.48 - $10.7 $1.13 Million - $1.62 Million
-151,721 Reduced 4.98%
2,897,748 $29.6 Million
Q2 2023

Aug 11, 2023

SELL
$7.2 - $9.47 $989,172 - $1.3 Million
-137,385 Reduced 4.31%
3,049,469 $23 Million
Q1 2023

May 11, 2023

BUY
$8.36 - $11.37 $4.98 Million - $6.77 Million
595,548 Added 22.98%
3,186,854 $28.2 Million
Q4 2022

Feb 13, 2023

BUY
$7.95 - $9.48 $3.81 Million - $4.54 Million
478,741 Added 22.66%
2,591,306 $23.6 Million
Q3 2022

Nov 08, 2022

BUY
$6.86 - $11.95 $2.56 Million - $4.46 Million
373,402 Added 21.47%
2,112,565 $17 Million
Q2 2022

Aug 12, 2022

BUY
$7.38 - $10.4 $382,365 - $538,834
51,811 Added 3.07%
1,739,163 $13.1 Million
Q1 2022

May 13, 2022

BUY
$7.33 - $9.39 $12.4 Million - $15.8 Million
1,687,352 New
1,687,352 $15.8 Million
Q2 2021

Aug 16, 2021

SELL
$9.9 - $11.56 $6.07 Million - $7.09 Million
-613,127 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$10.34 - $12.81 $15.6 Million - $19.3 Million
-1,506,839 Reduced 71.08%
613,127 $7.08 Million
Q4 2020

Feb 16, 2021

BUY
$8.61 - $11.04 $66,555 - $85,339
7,730 Added 0.37%
2,119,966 $20.5 Million
Q3 2020

Nov 13, 2020

SELL
$8.57 - $12.69 $3.59 Million - $5.32 Million
-419,138 Reduced 16.56%
2,112,236 $19 Million
Q2 2020

Aug 14, 2020

BUY
$8.12 - $13.12 $2.48 Million - $4.01 Million
305,830 Added 13.74%
2,531,374 $31.2 Million
Q1 2020

May 14, 2020

BUY
$6.69 - $13.45 $1.64 Million - $3.3 Million
245,022 Added 12.37%
2,225,544 $20 Million
Q4 2019

Feb 13, 2020

SELL
$6.53 - $10.72 $149,778 - $245,884
-22,937 Reduced 1.14%
1,980,522 $19.4 Million
Q3 2019

Nov 13, 2019

SELL
$6.16 - $9.6 $291,866 - $454,857
-47,381 Reduced 2.31%
2,003,459 $13.8 Million
Q2 2019

Aug 08, 2019

BUY
$8.12 - $15.72 $149,643 - $289,703
18,429 Added 0.91%
2,050,840 $18.9 Million
Q1 2019

May 13, 2019

SELL
$15.58 - $20.01 $2.09 Million - $2.68 Million
-134,167 Reduced 6.19%
2,032,411 $31.9 Million
Q4 2018

Feb 14, 2019

BUY
$14.59 - $23.84 $31.6 Million - $51.7 Million
2,166,578 New
2,166,578 $33.4 Million
Q2 2018

Aug 13, 2018

SELL
$16.77 - $24.71 $2.88 Million - $4.24 Million
-171,697 Closed
0 $0
Q1 2018

May 14, 2018

SELL
$16.68 - $22.07 $333,600 - $441,400
-20,000 Reduced 10.43%
171,697 $2.93 Million
Q4 2017

Feb 13, 2018

SELL
$11.23 - $19.1 $3.67 Million - $6.24 Million
-326,867 Reduced 63.03%
191,697 $3.63 Million
Q3 2017

Nov 13, 2017

BUY
$15.41 - $32.17 $708,829 - $1.48 Million
45,998 Added 9.73%
518,564 $9.13 Million
Q2 2017

Aug 14, 2017

SELL
N/A
-680,996 Reduced 59.03%
472,566 $15.6 Million
Q1 2017

Apr 17, 2019

SELL
N/A
-469,173 Reduced 28.91%
1,153,562 $37 Million
Q4 2016

Apr 17, 2019

BUY
N/A
5,659 Added 0.35%
1,622,735 $58.8 Million
Q3 2016

Apr 17, 2019

BUY
N/A
1,617,076
1,617,076 $74.5 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.